DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (104)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 104   Next >>

Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-25

Patient:

Reactions: Insomnia, Pyrexia, Somnolence, Lethargy

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-22

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-21



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Hypothyroidism, Pyrexia, Neutrophil Count Decreased

Drug(s) suspected as cause:
Interferon Beta NOS
    Dosage: 6 million iu, tiw
    Start date: 2010-11-17
    End date: 2011-09-16

Interferon Beta NOS
    Dosage: 6 million iu, qd
    Indication: Hepatitis C
    Start date: 2010-10-18
    End date: 2010-11-15

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2010-11-22
    End date: 2011-09-16

Rebetol
    Dosage: 200mg 400mg in evening in morning
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-10-18
    End date: 2010-11-21

Other drugs received by patient: Mucosta; Mucosta; Pegasys



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Transfusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-25

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-23

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Belgium on 2012-08-23

Patient:

Reactions: Nasal Obstruction, Fatigue, Anaemia, Condition Aggravated, Pyrexia, Oropharyngeal Pain, Streptococcal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-07-31

Rebetol
    Dosage: 1000 mg, bid
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-07-31

Victrelis
    Dosage: 2400 mg, tid
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-07-31



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-23

Patient:

Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Rebetol
    Dosage: 1400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Other drugs received by patient: Wellbutrin; Acetylsalicylic Acid SRT; Nebivolol HCL; Gabapentin



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Drug Ineffective, Pain, Pyrexia, Stress, Erythema, Weight Increased, Fatigue, Swelling

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-01-21

Rebetol
    Dosage: unk
    Administration route: Oral
    Start date: 2011-01-21

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-07
    End date: 2011-11-30



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Stomatitis, Anaemia, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 100 mg, once
    Administration route: Oral
    End date: 2012-03-06

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-21

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-07
    End date: 2012-02-13

Rebetol
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-06

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-28

Other drugs received by patient: Magmitt



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-22

Patient:

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 microgram per kilogram
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram
    Start date: 2012-05-23
    End date: 2012-07-18

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-26

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-07-24

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-05-02

Other drugs received by patient: Celestamine Combination; Loxonin; Famotidine; Celestamine Combination; Loxonin; Allopurinol



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded MK-5172
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Post Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded PRE Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: f
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: h
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: c
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: g
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: e
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: d
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: b
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: 4 df, tid
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-06-24

Blinded Therapy

Blinded Therapy

Blinded Therapy

Blinded Therapy
    Indication: Hepatitis C

Blinded Therapy

PEG-Intron
    Indication: Hepatitis C

PEG-Intron
    Dosage: 0.5 ml, qw
    Administration route: Oral
    Start date: 2012-01-10
    End date: 2012-06-19

Peginterferon Alfa-2B
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Placebo
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-10

Rebetol
    Dosage: 3 df, qpm
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-06

Rebetol
    Dosage: 2 df, qpm
    Administration route: Oral
    Start date: 2012-04-07
    End date: 2012-06-24

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-06-24

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-30

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-16

Ribavirin
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Nausea, Pyrexia, Headache, Suicidal Ideation, Eating Disorder, Insomnia, Depression, Decreased Appetite, Candidiasis

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-19

Victrelis
    Dosage: 4 df, tid

Victrelis
    Dosage: 40 mg, tid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-09-16

Victrelis
    Dosage: unk, tid
    Start date: 2011-08-19

Other drugs received by patient: Atarax; Diuretic (Unspecified); Xanax



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-15

Patient:

Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-18

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Other drugs received by patient: Digoxin; Losartan Potassium and Hydrochlorothiazide; Warfarin Sodium; Bisoprolol Fumarate; Lasix; Coniel; Warfarin Sodium; Bisoprolol Fumarate; Losartan Potassium and Hydrochlorothiazide; Digoxin; Losartan Potassium and Hydrochlorothiazide; Lasix; Coniel



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Other drugs received by patient: Bisoprolol Fumarate; Hydrochlorothiazide (+) Losartan Potassium; Bisoprolol Fumarate; Lasix; Lasix; Digoxin; Hydrochlorothiazide (+) Losartan Potassium; Warfarin Sodium; Digoxin; Coniel; Hydrochlorothiazide (+) Losartan Potassium; Warfarin Sodium; Coniel



Possible Rebetol side effects in

Reported by a physician from Italy on 2012-08-14

Patient:

Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Rebetol
    Dosage: 1400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Other drugs received by patient: Wellbutrin; Pantoprazole Sodium; Nebivolol HCL; Gabapentin



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient:

Reactions: Pyrexia, Hyperhidrosis

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Pyrexia, Neutropenia, Neutrophil Count Decreased, Erythema, Thrombocytopenia, Oropharyngeal Discomfort, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.72 mcg/kg/week
    Start date: 2012-01-25
    End date: 2012-01-25

PEG-Intron
    Dosage: 100 mcg/week
    Start date: 2012-06-12
    End date: 2012-06-25

PEG-Intron
    Dosage: 1.45 mcg/kg/week
    Start date: 2012-06-12
    End date: 2012-06-12

PEG-Intron
    Dosage: 1.44 mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Rebetol
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2012-06-12
    End date: 2012-06-25

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Other drugs received by patient: Urso 250; Urso 250



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Abdominal Pain, Fatigue, Bone Pain, Ocular Hyperaemia, Pyrexia, Constipation

Drug(s) suspected as cause:
PEG-Intron
    Dosage: redipen,150 microgram per 0.5 ml ,4 syringe per pack

Rebetol
    Dosage: 200 mg, unk

Telaprevir
    Dosage: 375 mg, unk

Other drugs received by patient: Acetaminophen / Hydrocodone Bitartrate; Magnesia [milk OF]; Amitiza; Etodolac; Alka-Seltzer



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Vomiting, Dehydration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, unk

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: LIP Swelling, Aphagia, Stomatitis, Urticaria, Renal Pain, Headache, Pyrexia, Asthenia, Anuria

Drug(s) suspected as cause:
Pegasys

Rebetol
    Dosage: fro 36 weeks length of therapy
    Administration route: Oral

Victrelis
    Administration route: Oral



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-09

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-09

Other drugs received by patient: Valium; Advil; Xanax; Ambien



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-09

Patient:

Reactions: Haemoglobin Decreased, Haematocrit Decreased, Hyperkalaemia, RED Blood Cell Count Decreased, Proteinuria, Pyrexia, Depression, Neutrophil Count Decreased

Drug(s) suspected as cause:
Interferon Beta NOS
    Dosage: 6 million iu, tiw
    Start date: 2010-07-21
    End date: 2011-05-18

Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2010-06-21
    End date: 2010-07-05

Interferon Beta NOS
    Dosage: 6 million iu, qd
    Start date: 2010-07-06
    End date: 2010-07-19

Interferon Beta NOS
    Start date: 2010-07-06
    End date: 2010-07-19

Interferon Beta NOS
    Dosage: 3 million iu, bid
    Indication: Hepatitis C
    Start date: 2010-06-21
    End date: 2010-07-05

Interferon Beta NOS
    Start date: 2010-07-21
    End date: 2011-05-18

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2010-08-04
    End date: 2011-05-18

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2010-07-21
    End date: 2010-08-03

Rebetol
    Dosage: 200mg400mg in evening in morning
    Administration route: Oral
    Start date: 2010-06-21
    End date: 2010-07-20

Other drugs received by patient: Adalat CC; Urso 250; Urso 250; Adalat CC; Depas



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-09

Patient:

Reactions: Stomatitis, Anaemia, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 100 mg, qd
    Administration route: Oral
    End date: 2012-03-06

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-21

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-07
    End date: 2012-02-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-01-17
    End date: 2012-02-06

Other drugs received by patient: Myser (Difluprednate); Allegra; Telaprevir; Talion (Bepotastine Besylate); Xyzal; Magmitt



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient:

Reactions: Dyspnoea, Retching, Nausea, Pyrexia, Constipation, Fatigue, Palpitations, Dizziness, Asthenia, Influenza Like Illness

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: 150 ?g, unknown
    Indication: Hepatitis C

Rebetol
    Dosage: 200 mg, unknown
    Indication: Hepatitis C

Other drugs received by patient: Estradiol (+) Norethindrone; Tylenol (Caplet); Neupogen; Prochlorperazine; Procrit; Prozac



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient:

Reactions: Weight Decreased, White Blood Cell Count Decreased, Abdominal Pain, Anaemia, Chills, Rash, Pyrexia, Oral Herpes, Hyperhidrosis, Fatigue, RED Blood Cell Count Decreased, Diarrhoea, Platelet Count Decreased

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C

Rebetol
    Dosage: 200 mg, unk
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

Other drugs received by patient: Rituxan; Citalopram Hydrobromide; Vitamins (Unspecified); Neupogen; Procrit; Lisinopril



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Greece on 2012-08-01

Patient:

Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03

Rebetol
    Dosage: 1200 mg, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qd

Pegasys
    Dosage: 180mcg,once a week

Rebetol
    Dosage: 1200 mg, qd

Victrelis
    Dosage: 200mg,4tablets,three times a day

Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Pyrexia, Hypokalaemia, Anxiety, Proteinuria, Hypoalbuminaemia, Platelet Count Decreased, Depression

Drug(s) suspected as cause:
Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2009-11-05
    End date: 2009-12-01

Interferon Beta NOS
    Start date: 2009-12-03

Rebetol
    Dosage: 200mg in the evening and 400mg in the morning
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-11-05

Other drugs received by patient: Norvasc; Depas; Theolong; Lendormin; Fluvastatin; Famotidine; Halcion



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Diarrhoea, Alopecia, Pancytopenia, Pyrexia, Headache, Neutrophil Count Decreased

Drug(s) suspected as cause:
Copegus
    Dosage: 400 mg in the morning and 200 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-12-27

Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2010-09-16
    End date: 2010-09-21

Interferon Beta NOS
    Start date: 2010-10-18
    End date: 2010-12-24

Interferon Beta NOS
    Start date: 2010-09-24
    End date: 2010-10-16

Pegasys
    Dosage: 180 qw
    Indication: Hepatitis C
    Start date: 2010-12-27

Rebetol
    Dosage: 200 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-09-16
    End date: 2010-12-24

Other drugs received by patient: Alfarol; Singulair Tablets 10mg; Advair Diskus 100 / 50; Onealfa



Possible Rebetol side effects in 75 year old male

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient: 75 year old male

Reactions: Rhabdomyolysis, Henoch-Schonlein Purpura, Platelet Count Decreased, Oropharyngeal Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: dosage is uncertain.
    Indication: Hepatitis C
    Start date: 2006-12-01

Rebetol
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2006-12-01



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient:

Reactions: Drug Eruption, Pyrexia, Erythema Multiforme, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-09

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-14

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-17

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-03-29

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-12

Telavic
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-14

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-09

Other drugs received by patient: Prednisolone; Prednisolone; Diclofenac Sodium; Betamethasone; Clobetasol Propionate; Olopatadine HCL; Prednisolone; Prednisolone; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec; Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-27



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017